IBRX

7.30

2.24% 0.16

Dopo l'orario di chiusura: 7.24 -0.06 -0.82%

Immunitybio Inc (IBRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IBRX Giù? Forum Previsione

Precedente Chiudi:

$7.14

Aprire:

$6.89

Volume 24 ore:

14.05M

Relative Volume:

0.38

Capitalizzazione di mercato:

$7.54B

Reddito:

$113.29M

Utile/perdita netta:

$-351.47M

Rapporto P/E:

-18.73

EPS:

-0.3898

Flusso di cassa netto:

$-309.19M

1 W Prestazione:

-1.08%

1M Prestazione:

-30.08%

6M Prestazione:

+192.00%

1 anno Prestazione:

+139.34%

Intervallo 1D:

$6.88

$7.35

Intervallo di 1 settimana:

$6.57

$7.85

Portata 52W:

$1.83

$12.43

Immunitybio Inc Stock (IBRX) Company Profile

Nome

Immunitybio Inc

Settore

Healthcare (1118)

Industria

Biotechnology (624)

Telefono

(844) 696-5235

Indirizzo

3530 JOHN HOPKINS COURT, SAN DIEGO

Dipendente

691

Cinguettio

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

IBRX's Discussions on Twitter

Compare IBRX vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IBRX Immunitybio Inc	7.30	7.54B	113.29M	-351.47M	-309.19M	-0.3898
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-12	Ripresa	BTIG Research	Buy
2025-05-20	Aggiornamento	Piper Sandler	Neutral → Overweight
2025-03-06	Iniziato	H.C. Wainwright	Buy
2025-01-10	Iniziato	BTIG Research	Buy
2023-05-12	Downgrade	Piper Sandler	Overweight → Neutral
2022-08-03	Iniziato	Jefferies	Buy

Mostra tutto

Immunitybio Inc Borsa (IBRX) Ultime notizie

12:00 PM

Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - kdhnews.com

12:00 PM

05:59 AM

Securing Non-Dilutive Funding to Support Immunotherapy Platform Growth – ImmunityBio - Oncodaily

05:59 AM

05:00 AM

ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before ... - Black Hills Pioneer

05:00 AM

04:55 AM

CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Downgrade) - seekingalpha.com

04:55 AM

Apr 04, 2026

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Snowflake Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Apr 04, 2026

ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. - GlobeNewswire

Apr 04, 2026

ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up - TipRanks

Apr 04, 2026

IBRX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 - PR Newswire

Apr 04, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation - accessnewswire.com

Apr 04, 2026

Investors with Substantial Losses in ImmunityBio (IBRX) Have Opportunity to Lead Class Action Lawsuit - National Today

Apr 04, 2026

Apr 03, 2026

INVESTOR NOTICE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

Apr 03, 2026

IBRX INVESTOR ALERT: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman - PR Newswire

Apr 03, 2026

ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc.IBRX - PR Newswire

Apr 03, 2026

Deadline Alert: ImmunityBio, Inc. (IBRX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - Carroll County Mirror-Democrat

Apr 03, 2026

When a podcast becomes promotion: Inside the FDA’s warning shot at ImmunityBio - Medical Marketing and Media

Apr 03, 2026

IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Apr 03, 2026

NYSE: PINS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Pinterest, Inc. - GlobeNewswire Inc.

Apr 03, 2026